sodium--2-(1,3-benzothiazol-2-yl)-4-methyl-5-[2-(morpholin-4-yl)ethyl]-3,6-dioxo-2,3,5,6-tetrahydropyrazolo[4,3-c]pyridin-1-ide (1/1)
Chemical Structure Depiction of
sodium--2-(1,3-benzothiazol-2-yl)-4-methyl-5-[2-(morpholin-4-yl)ethyl]-3,6-dioxo-2,3,5,6-tetrahydropyrazolo[4,3-c]pyridin-1-ide (1/1)
sodium--2-(1,3-benzothiazol-2-yl)-4-methyl-5-[2-(morpholin-4-yl)ethyl]-3,6-dioxo-2,3,5,6-tetrahydropyrazolo[4,3-c]pyridin-1-ide (1/1)
Compound characteristics
Compound ID: | 8249-3507 |
Compound Name: | sodium--2-(1,3-benzothiazol-2-yl)-4-methyl-5-[2-(morpholin-4-yl)ethyl]-3,6-dioxo-2,3,5,6-tetrahydropyrazolo[4,3-c]pyridin-1-ide (1/1) |
Molecular Weight: | 433.46 |
Molecular Formula: | C20 H20 N5 O3 S |
Salt: | Na+ |
Smiles: | CC1=C2C(=CC(N1CCN1CCOCC1)=O)[N-]N(C2=O)c1nc2ccccc2s1 |
Stereo: | ACHIRAL |
logP: | 1.5604 |
logD: | 1.5388 |
logSw: | -2.2662 |
Hydrogen bond acceptors count: | 8 |
Polar surface area: | 66.665 |
InChI Key: | DFCKDXFAPTZVAF-UHFFFAOYSA-M |